(Q44887089)

7 December 2017

Intravesical gemcitabine in BCG-refractory T1G3 transitional cell carcinoma of the bladder: a pilot study (English)

1 reference

transitional cell carcinoma

7 December 2017

1 reference

1

1 reference

7 December 2017

2

1 reference

7 December 2017

Tommaso Cai

3

1 reference

7 December 2017

Stefano Nerozzi

4

1 reference

7 December 2017

Novello Pinzi

5

1 reference

7 December 2017

Fabrizio Repetti

6

1 reference

7 December 2017

Fabrizio Viggiani

7

1 reference

7 December 2017

Paolo Ghezzi

8

1 reference

7 December 2017

Gabriella Nesi

9

1 reference

7 December 2017

Marco Carini

10

1 reference

7 December 2017

TUR (Toscana Urologia) Group

11

1 reference

7 December 2017

1 January 2006

1 reference

7 December 2017

Urologia Internationalis

1 reference

7 December 2017

76

1 reference

7 December 2017

106-111

1 reference

7 December 2017

2

1 reference

Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction

7 December 2017

1 reference

Tumor progression and survival in patients with T1G3 bladder tumors: multicentric retrospective study comparing 94 patients treated during 17 years

21 January 2018

1 reference

Intravesical bacille Calmette-Guérin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression.

21 January 2018

1 reference

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

21 January 2018

1 reference

Phase I pharmacokinetic study of a single intravesical instillation of gemcitabine administered immediately after transurethral resection plus multiple random biopsies in patients with superficial bladder cancer

21 January 2018

1 reference

A second-look TUR in T1 transitional cell carcinoma: why?

21 January 2018

1 reference

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee

21 January 2018

1 reference

Second-line intravesical therapy versus cystectomy for bacille Calmette-Guérin (BCG) failures

21 January 2018

1 reference

Intravesical gemcitabine therapy for superficial transitional cell carcinoma of the bladder: a phase I and pharmacokinetic study

21 January 2018

1 reference

Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000090870

1 reference

7 December 2017

1 reference